Parkman Healthcare Partners LLC Silence Therapeutics PLC Transaction History
Parkman Healthcare Partners LLC
- $687 Million
- Q4 2024
A detailed history of Parkman Healthcare Partners LLC transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 491,080 shares of SLN stock, worth $2.35 Million. This represents 0.49% of its overall portfolio holdings.
Number of Shares
491,080
Previous 497,870
1.36%
Holding current value
$2.35 Million
Previous $9.06 Million
62.7%
% of portfolio
0.49%
Previous 1.28%
Shares
11 transactions
Others Institutions Holding SLN
# of Institutions
66Shares Held
24.6MCall Options Held
500Put Options Held
5K-
Tcg Crossover Management, LLC Palo Alto, CA3.03MShares$14.5 Million3.41% of portfolio
-
Siren, L.L.C. New York, NY2.83MShares$13.6 Million0.86% of portfolio
-
Redmile Group, LLC San Francisco, CA2.4MShares$11.5 Million1.29% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY1.86MShares$8.89 Million1.01% of portfolio
-
Morgan Stanley New York, NY1.66MShares$7.97 Million0.0% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $172M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...